FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309614502> ?p ?o ?g. }

• W4309614502 abstract "Osteoarthritis is a very disabling disease that can be treated with both non-pharmacological and pharmacological approaches. In the last years, pharmaceutical-grade chondroitin sulfate (CS) and glucosamine emerged as symptomatic slow-acting molecules, effective in pain reduction and improved function in patients affected by osteoarthritis. CS is a sulfated glycosaminoglycan that is currently produced mainly by extraction from animal tissues, and it is commercialized as a pharmaceutical-grade ingredient and/or food supplement. However, public concern on animal product derivatives has prompted the search for alternative non-extractive production routes. Thus, different approaches were established to obtain animal-free natural identical CS. On the other hand, the unsulfated chondroitin, which can be obtained via biotechnological processes, demonstrated promising anti-inflammatory properties in vitro, in chondrocytes isolated from osteoarthritic patients. Therefore, the aim of this study was to explore the potential of chondroitin, with respect to the better-known CS, in an in vivo mouse model of knee osteoarthritis. Results indicate that the treatment with biotechnological chondroitin (BC), similarly to CS, significantly reduced the severity of mechanical allodynia in an MIA-induced osteoarthritic mouse model. Decreased cartilage damage and a reduction of inflammation- and pain-related biochemical markers were also observed. Overall, our data support a beneficial activity of biotechnological unsulfated chondroitin in the osteoarthritis model tested, thus suggesting BC as a potential functional ingredient in pharmaceuticals and nutraceuticals with the advantage of avoiding animal tissue extraction." @default.
• W4309614502 created "2022-11-28" @default.
• W4309614502 creator A5002742138 @default.
• W4309614502 creator A5004366533 @default.
• W4309614502 creator A5006188708 @default.
• W4309614502 creator A5006317571 @default.
• W4309614502 creator A5016749037 @default.
• W4309614502 creator A5024581031 @default.
• W4309614502 creator A5039964066 @default.
• W4309614502 creator A5044045902 @default.
• W4309614502 creator A5047667967 @default.
• W4309614502 creator A5048276688 @default.
• W4309614502 creator A5049717032 @default.
• W4309614502 creator A5080203719 @default.
• W4309614502 date "2022-11-17" @default.
• W4309614502 modified "2023-09-30" @default.
• W4309614502 title "Evaluation of unsulfated biotechnological chondroitin in a knee osteoarthritis mouse model as a potential novel functional ingredient in nutraceuticals and pharmaceuticals" @default.
• W4309614502 cites W1967927251 @default.
• W4309614502 cites W1968475366 @default.
• W4309614502 cites W2005620572 @default.
• W4309614502 cites W2006458534 @default.
• W4309614502 cites W2011038175 @default.
• W4309614502 cites W2021570058 @default.
• W4309614502 cites W2056742992 @default.
• W4309614502 cites W2066771279 @default.
• W4309614502 cites W2083092719 @default.
• W4309614502 cites W2085176255 @default.
• W4309614502 cites W2090374043 @default.
• W4309614502 cites W2098163320 @default.
• W4309614502 cites W2108552642 @default.
• W4309614502 cites W2117040516 @default.
• W4309614502 cites W2121319738 @default.
• W4309614502 cites W2129822434 @default.
• W4309614502 cites W2135037584 @default.
• W4309614502 cites W2164352999 @default.
• W4309614502 cites W2165368371 @default.
• W4309614502 cites W2168438949 @default.
• W4309614502 cites W2315063842 @default.
• W4309614502 cites W2334040429 @default.
• W4309614502 cites W2348185624 @default.
• W4309614502 cites W2577967191 @default.
• W4309614502 cites W2789641317 @default.
• W4309614502 cites W2893611617 @default.
• W4309614502 cites W2895182203 @default.
• W4309614502 cites W2949771071 @default.
• W4309614502 cites W2965411998 @default.
• W4309614502 cites W3021918898 @default.
• W4309614502 cites W3028313314 @default.
• W4309614502 cites W3031863062 @default.
• W4309614502 cites W3047530376 @default.
• W4309614502 cites W3107012386 @default.
• W4309614502 cites W3134420050 @default.
• W4309614502 cites W3154691313 @default.
• W4309614502 cites W3164485448 @default.
• W4309614502 cites W3164652214 @default.
• W4309614502 cites W3185544276 @default.
• W4309614502 cites W4210716415 @default.
• W4309614502 cites W4242837626 @default.
• W4309614502 doi "https://doi.org/10.3389/fbioe.2022.934997" @default.
• W4309614502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36466352" @default.
• W4309614502 hasPublicationYear "2022" @default.
• W4309614502 type Work @default.
• W4309614502 citedByCount "2" @default.
• W4309614502 countsByYear W43096145022023 @default.
• W4309614502 crossrefType "journal-article" @default.
• W4309614502 hasAuthorship W4309614502A5002742138 @default.
• W4309614502 hasAuthorship W4309614502A5004366533 @default.
• W4309614502 hasAuthorship W4309614502A5006188708 @default.
• W4309614502 hasAuthorship W4309614502A5006317571 @default.
• W4309614502 hasAuthorship W4309614502A5016749037 @default.
• W4309614502 hasAuthorship W4309614502A5024581031 @default.
• W4309614502 hasAuthorship W4309614502A5039964066 @default.
• W4309614502 hasAuthorship W4309614502A5044045902 @default.
• W4309614502 hasAuthorship W4309614502A5047667967 @default.
• W4309614502 hasAuthorship W4309614502A5048276688 @default.
• W4309614502 hasAuthorship W4309614502A5049717032 @default.
• W4309614502 hasAuthorship W4309614502A5080203719 @default.
• W4309614502 hasBestOaLocation W43096145021 @default.
• W4309614502 hasConcept C142724271 @default.
• W4309614502 hasConcept C150903083 @default.
• W4309614502 hasConcept C153074725 @default.
• W4309614502 hasConcept C17857428 @default.
• W4309614502 hasConcept C185592680 @default.
• W4309614502 hasConcept C204787440 @default.
• W4309614502 hasConcept C207001950 @default.
• W4309614502 hasConcept C2776164576 @default.
• W4309614502 hasConcept C2776735749 @default.
• W4309614502 hasConcept C2779553658 @default.
• W4309614502 hasConcept C2780589914 @default.
• W4309614502 hasConcept C55493867 @default.
• W4309614502 hasConcept C71924100 @default.
• W4309614502 hasConcept C86803240 @default.
• W4309614502 hasConcept C98274493 @default.
• W4309614502 hasConceptScore W4309614502C142724271 @default.
• W4309614502 hasConceptScore W4309614502C150903083 @default.
• W4309614502 hasConceptScore W4309614502C153074725 @default.
• W4309614502 hasConceptScore W4309614502C17857428 @default.
• W4309614502 hasConceptScore W4309614502C185592680 @default.
• W4309614502 hasConceptScore W4309614502C204787440 @default.
• W4309614502 hasConceptScore W4309614502C207001950 @default.

• next